Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 54,686 shares at $110.64 ($6.2M) on 2021-11-04, disclosed to the SEC on 2021-11-05.
Open-market sale of $6.2M HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.64 | 5,484 | $607K | 9.8% |
| 2 | $110.64 | 5,484 | $607K | 9.8% |
| 3 | $111.47 | 6,336 | $706K | 11.4% |
| 4 | $111.47 | 6,336 | $706K | 11.4% |
| 5 | $112.44 | 2,706 | $304K | 4.9% |
| 6 | $112.44 | 2,706 |
| $304K |
| 4.9% |
| 7 | $113.54 | 5,650 | $642K | 10.4% |
| 8 | $114.49 | 2,728 | $312K | 5.1% |
| 9 | $114.49 | 2,728 | $312K | 5.1% |
| 10 | $115.51 | 7,264 | $839K | 13.6% |
| 11 | $115.51 | 7,264 | $839K | 13.6% |
| Total | $112.99 avg | 54,686 | $6.2M | 100% |
| Filing → |
| HZNP | SELL | 2022-07-29 | $801K | — | Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |